Cogent Biosciences
$8.649876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$8.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.35 (+4.22%) Today
$0.00 (0.00%) As of 11:06 AM UTC after-hours
Why Robinhood?
You can buy or sell COGT and other stocks, options, and ETFs commission-free!
About COGT
Cogent Biosciences, Inc. Common Stock, also called Cogent Biosciences, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of precision therapies for genetically defined diseases.
CEO
Andrew R. Robbins
Employees
15
Headquarters
Cambridge, Massachusetts
Founded
2014
Market Cap
321.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
269.14K
High Today
$8.65
Low Today
$8.00
Open Price
$8.27
Volume
628.87K
52 Week High
$14.88
52 Week Low
$1.36
COGT Earnings
-$6.06
-$4.04
-$2.02
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, Pre-Market